Insulin pump vs shots for blood sugar during sudden hearing loss treatment
Part of Brain & nervous system, Ear, nose & throat, Hormones & metabolism clinical trials.
This trial tests whether using a continuous glucose monitor (CGM) with an insulin patch pump controls blood sugar better than standard insulin shots during steroid treatment for sudden hearing loss. The goal is to find a safer, more convenient way to manage steroid-related blood sugar spikes, keeping you comfortable while treating your hearing.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 19 years old or older.
- You have sudden hearing loss in one ear diagnosed within the last 3 days, with at least moderate hearing loss.
- You have type 2 diabetes, or your blood sugar is higher than normal (as shown by recent tests).
- You are scheduled to take a steroid pill called methylprednisolone (48 mg once daily in the morning).
- You are able to eat at least 2 meals a day and can use a smartphone, a continuous glucose monitor (CGM), and an insulin patch pump.
- You are willing to stay in the hospital for 2 nights and give written consent.
- You are not using an insulin pump currently and have no allergy to medical adhesives.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a special patch that helps keep continuous glucose monitor (CGM) sensors in place longer. It is for people with diabetes who have trouble keeping their sensor on and have high blood sugar levels.
This trial tests a new way to give insulin using a patch on your skin instead of a needle. It could make managing your blood sugar easier and help you avoid daily injections.
This study compares a continuous “under the skin” diabetes medicine (called beinaglutide) with an insulin pump (CSII) in people who were recently diagnosed with type 2 diabetes. It aims to see which approach works better and is safer for controlling blood sugar.
This study compares two ways to manage blood sugar in the hospital for people with type 2 diabetes: an automated insulin delivery system (a pump worn on the body with a continuous glucose monitor) versus the usual daily insulin injections. The goal is to see if the automated system keeps blood sugar in a safer range during an acute illness.
This study tests using a continuous glucose monitor (a small sensor that checks blood sugar all the time) to help guide the dose of insulin given through an IV. This is for patients who are not in the ICU but need insulin therapy for over a day, especially those on steroids or special nutrition.
This trial tests whether a GLP-1 receptor agonist (a type of diabetes medication) can safely and effectively treat high blood sugar caused by long-term steroid use. It may help people with type 2 diabetes or steroid-induced diabetes who take oral steroids for conditions like asthma, arthritis, or kidney disease.
Hear when a new Sudden Sensorineural Hearing Loss (SSNHL) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.